Daph was reported to inhibit the abnormal proliferation of keratinocytes by inhibiting the NF-κB signaling pathway, thus reducing the release of inflammatory factors and alleviating the symptoms of psoriasis. This evidence concerns the gene NFKB1 and psoriasis.